Latest News
Eli Lilly Lifts 2026 Guidance After GLP-1 Sales Surge 56% in Q1
Eli Lilly boosted its 2026 revenue outlook by $2 billion after Q1 sales jumped 56% to $19.8 billion, propelled by Mounjaro and Zepbound. The company also launched oral GLP-1 pill Foundayo.
Caterpillar Profit Surges on AI Data Center Demand, Tariff Costs Loom
Caterpillar Q1 adjusted EPS of $5.54 beat estimates on 41% power-generation growth from AI data centers. Shares rose 5% premarket; tariff costs seen at $2.2-$2.4B.
Microsoft's $190B AI Outlay Signals Cloud Dominance Push
Microsoft posts solid Q3 results with Azure growth beating estimates, but shares dip as the company outlines $190B in AI infrastructure spending through 2026.
AWS Growth Accelerates, Amazon Stock Gains on Cloud AI Demand
Amazon shares rose 1.4% as AWS revenue surged 28% to $37.6B, its fastest growth in 15 quarters, signaling strong AI-driven cloud demand.
KeyCorp Expands into Western Europe with Clearwater UK Acquisition
KeyCorp acquires Clearwater UK, marking its first Western Europe advisory platform. The deal, expected to close in late 2026, expands KeyBanc's M&A and debt advisory capabilities.
Brent Crude Plunges After Spiking Above $126 on Iran Tensions
Brent crude briefly topped $126 a barrel before sliding to $115.98 as markets weighed US military options against Iran and potential disruptions at the Strait of Hormuz.
Alphabet Surges as Google Cloud Revenue Hits $20 Billion, AI Spend Pays Off
Alphabet shares surged 6.1% in premarket trading after Google Cloud revenue jumped 63% to a record $20 billion, driving a Q1 earnings beat. Net income rose 81% to $62.6 billion.
Meta Platforms Drops as $145B AI Capex Plan Overshadows Strong Q1 Earnings
Meta Platforms shares dropped over 6% after hours after unveiling a $125-$145 billion 2026 AI capex plan, overwhelming a strong Q1 earnings beat with revenue up 33% and net income up 61%.
